Chai-3
ModelAdvanced molecular-design model used with pharmaceutical partners to pursue previously difficult therapeutic targets.
- Jun 4, 2026
- —
- —
- —
- —
- 1
Releases
Jun 4, 2026Chai-3 enters pharmaceutical partner useModel release
Chai disclosed Chai-3 as its most advanced molecular-design model through a licensing collaboration with Pfizer.

